Skip to contentSkip to Braille Studio

Library / Laws / 114th / s / S. 3224 / Introduced in Senate

S. 3224 — Introduced in Senate

284 words · about 1 min to read

Download .txt All versions Braille ⠃⠗⠋ Print Cite

II 114th CONGRESS 2d Session S. 3224 IN THE SENATE OF THE UNITED STATES July 14, 2016 Mr. Grassley (for himself, Mr. Schumer, Mr. Cornyn, Mrs. Feinstein, and Ms. Klobuchar) introduced the following bill; which was read twice and referred to the Committee on the Judiciary A BILL To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes. 1. Short title This Act may be cited as the Dangerous Synthetic Drug Control Act of 2016. 2. Treatment of certain designer drugs as schedule I controlled substances (a) Cannabimimetic agents Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)— (1) in clause (xiv) by striking and at the end; (2) in clause (xv) by striking the period and inserting a semicolon; and (3) by adding at the end the following: (xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251); (xvii) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073); (xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302); (xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA); (xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22); (xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA); (xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24); (xxiii) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201); (xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA); (xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and (xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MACHMINACA). . (b) Synthetic opioids Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following: (43) Butyryl fentanyl. (44) beta-Hydroxythiofentanyl. (45) Acetyl fentanyl. . (c) Other drugs Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following: (29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone). (30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB). (31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB). (32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI). (33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI). (34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly). (35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC). (36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM). .